financetom
Business
financetom
/
Business
/
Update: MCAN Mortgage Lifts Q1 Dividend Even as Q4 2024 Earnings Miss Estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: MCAN Mortgage Lifts Q1 Dividend Even as Q4 2024 Earnings Miss Estimates
Feb 25, 2025 9:12 AM

11:54 AM EST, 02/25/2025 (MT Newswires) -- (Updates shares)

MCAN Mortgage ( MAMTF ) reported after Monday's close a hike to its first-quarter dividend even though net income in the fourth quarter of 2024 fell short of analysts' expectations.

The board declared a regular cash dividend of $0.41 per share for the first quarter, a 5% increase from its dividend in the fourth quarter of 2024. The dividend is payable March 31 to shareholders of record as of March 14.

The company posted net income of $7.7 million, or $0.20 per share, a decline from the $19.9 million, or $0.56 per share, booked a year ago. The FactSet analyst consensus estimate had forecast $0.47 per share.

MCAN said its fourth-quarter 2024 results were impacted by higher net unrealized fair value losses on its REIT and non-marketable securities portfolios, as well as higher operating expenses.

"We are focused on MCAN's strategic positioning in the Canadian residential mortgage market and preserving long-term value for our shareholders in the uncertain economic environment," interim CEO Derek Sutherland said.

MCAN's share were last seen down $0.33 to $18.11 on the Toronto Stock Exchange.

Price: 18.14, Change: -0.30, Percent Change: -1.63

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Johnson & Johnson discontinues dengue drug study
Johnson & Johnson discontinues dengue drug study
Oct 4, 2024
Oct 4 (Reuters) - Johnson & Johnson ( JNJ ) said on Friday it will discontinue its mid-stage field study evaluating the efficacy of its antiviral drug candidate for the prevention of dengue. ...
J&J discontinues dengue drug study
J&J discontinues dengue drug study
Oct 4, 2024
(Reuters) -Johnson & Johnson ( JNJ ) said on Friday it will discontinue a mid-stage field study evaluating the efficacy of its antiviral drug candidate for the prevention of dengue. The decision to discontinue the study was part of a reprioritization of the company's communicable diseases research and development portfolio, J&J said. In another mid-stage study, six of 10 participants...
Tellurian shareholders back proposed $1.2 billion Woodside deal
Tellurian shareholders back proposed $1.2 billion Woodside deal
Oct 4, 2024
(Reuters) - Tellurian shareholders have voted in favor of the U.S. LNG developer's proposed $1.2 billion acquisition by Australian energy producer Woodside Energy Group, the company said on Friday. Shares rose 1.4% to 98 cents in premarket trade. Woodside in July agreed to buy Tellurian, including its U.S. Gulf Coast Driftwood LNG export project. The agreement is expected help solve...
DMG Blockchain Solutions Announced Preliminary September 2024 Operational Results
DMG Blockchain Solutions Announced Preliminary September 2024 Operational Results
Oct 4, 2024
09:15 AM EDT, 10/04/2024 (MT Newswires) -- DMG Blockchain Solutions Inc. ( DMGGF ) , a vertically integrated blockchain and data center technology company, announced Friday its preliminary Bitcoin operational results for September 2024. Among highlights, DMG cited bitcoin mined of 23 BTC; hashrate of 1.1 EH/s; and bitcoin holdings of 436 BTC. In a hosting update, DMG said it...
Copyright 2023-2026 - www.financetom.com All Rights Reserved